MedPath

Immune response ten years after yellow fever vaccination in the elderly traveller.

Conditions
Yellow fever. Long term induced seroprotection after primary yellow fever vaccination.
Registration Number
NL-OMON24129
Lead Sponsor
A.H.E. Roukens and L.G. Visser
Brief Summary

Initial trial: Roukens et al (2011), PLoS ONE. Doi:10.1371/journal.pone.0027753

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

The study aims to include all participants of a prospective controlled cohort study conducted in 2008-2009, investigating the immune response after primary yellow fever vaccination.

Exclusion Criteria

Booster yellow fever vaccination after the initial trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Geometric mean titer (GMT) of YF neutralizing antibodies.<br>2.Percentage of participants with seroprotection.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath